The latest cancer drugs news
Browsing: Cancer Drug News
First targeted therapy for multiple myeloma effective against hard-to-treat disease
ASH: Myeloma is cancer of the plasma cells, white blood cells that produce infection-fighting antibodies.…
Experimental drug is first targeted therapy to improve survival in high-risk AML patients
ASH: Midostaurin added to standard chemotherapy is the first targeted treatment to improve survival of…
Promising drug combination for advanced prostate cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary…
Prioritising patients over profits
Australia’s first ‘for-benefit’ pharmaceutical company directing 100% of profits to patient support & medical research…
Possible new mechanism for aspirin’s role in cancer prevention
Aspirin has been shown to decrease the risk of colorectal cancer and possibly other cancers.…
FDA approves osimertinib for non-small cell lung cancer
The US Food and Drug Administration has granted accelerated approval to osimertinib (Tagrisso) once daily…
Cancer Drugs Fund: Kadcyla back on list
By Smitha Mundasad – BBC. The Cancer Drugs Fund will continue to pay for the…
Blood test picks out prostate cancer drug resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a…
Landmark clinical trial shows gene-targeted drug can treat prostate cancer
A pioneering drug developed to treat women with inherited cancers can also benefit men with…
Antiangiogenic breast cancer treatment may benefit only patients with well-perfused tumours
A Massachusetts General Hospital (MGH) research team, in collaboration with investigators at the Dana-Farber Cancer…